|
TTC30A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
1.12354570092066E-13 |
| Normal-vs-Stage3 |
1.62436730732907E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
4.316200E-02 |
| Stage1-vs-Stage3 |
4.129800E-01 |
| Stage1-vs-Stage4 |
1.036340E-04 |
| Stage2-vs-Stage3 |
1.699830E-02 |
| Stage2-vs-Stage4 |
8.48770000000387E-05 |
| Stage3-vs-Stage4 |
8.058100E-03 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
4.01359945279012E-10 |
| Normal-vs-Asian |
1.62447832963153E-12 |
| Caucasian-vs-AfricanAmerican |
2.334400E-01 |
| Caucasian-vs-Asian |
1.290010E-01 |
| AfricanAmerican-vs-Asian |
1.314560E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
6.706600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
4.45519999999755E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.213800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.996000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.154800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.755400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.661000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.578800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.16019999957851E-07 |
| Classical-VS-Follicular |
8.04080000000873E-05 |
| Classical-VS-Other |
9.514800E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
3.30769855949598E-11 |
| Tall-VS-Other |
2.619000E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
2.242000E-01 |
| Follicular-VS-Normal |
1.68309810533174E-12 |
| Other-VS-Normal |
1.65865999999237E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
2.07939999999907E-05 |
|
|
